Periodoncia.Eley.6a.Ed

268 Periodoncia
Golub LM, Ramamurthy NS, McNamara TF, et al: Tetracyclines inhibit tissue collagenase
activity: a new mechanism in the treatment of periodontal disease, J Periodontal Res
19:651–655, 1984.
Golub LM, Wolff M, Lee HM, et al: Further evidence that tetracyclines inhibit
collagenase activity in human crevicular fluid and from other mammalian sources,
J Periodontal Res 20:12–23, 1985.
Golub LM, McNamara TF, D’Angelo G, et al: A non-antimicrobial chemically-modified
tetracycline inhibits mammalian collagenase activity, J Dent Res 66:1310–1314, 1987.
Golub LM, Ramamurthy NS, McNamara TF: Tetracyclines inhibit connective tissue
breakdown: new therapeutic implications for an old family of drugs, Crit Rev Oral Biol
Med 2:297–322, 1991.
Golub LM, Suomalainen K, Sorsa T: Host modulation with tetracyclines and their
chemically modified analogues, Curr Sci Curr Opin Dent 2:80–90, 1992.
Golub LM, Evans RT, McNamara TF, et al: A non-antimicrobial tetracycline inhibits
gingival matrix metalloproteinases and bone loss in Porphyromonas gingivalisinduced
periodontitis in rats, Ann N Y Acad Sci 732:96–111, 1994.
Golub LM, Sorsa T, Lee H-M, et al: Doxycycline inhibits neutrophil (PMN)-type matrix
metalloproteinases in adult periodontitis gingiva, J Clin Periodontol 22:100–109,
1995.
Goodson JM: Pharmacokinetics principles controlling efficacy of oral therapy, J Dent Res
68:1625–1632, 1989.
Goodson JM: Antimicrobial strategies or treatment of periodontal disease, Periodontol
2000 5:142–168, 1994.
Goodson JM, Tanner A: Antibiotic resistance of the subgingival microflora following
local tetracycline therapy, Oral Microbiol Immunol 7:113–117, 1992.
Goodson JM, Haffajee AD, Socransky SS: Periodontal therapy by local delivery of
tetracycline, J Clin Periodontol 6:83–92, 1979.
Goodson JM, Holborow D, Dunn R, et al: Monolithic tetracycline containing fibres for
control delivery to periodontal pockets, J Periodontol 54:575–579, 1983.
Goodson JM, Hogan PE, Dunham SL: Clinical responses following periodontal treatment
by local drug delivery, J Periodontol 56:81–87, 1985.
Goodson JM, Ugini MA, Kent RL, et al: Multicenter evaluation of tetracycline fibre
therapy: I, experimental design, methods and baseline data, J Periodontal Res
26:361–370, 1991a.
Goodson JM, Ugini MA, Kent RL, et al: Multicenter evaluation of tetracycline fibre
therapy: II. Clinical response, J Periodontal Res 26:371–379, 1991b.
Goodson JM, Tanner A, McArdle S, et al: Multicenter evaluation of tetracycline fibre
therapy: III. microbiological response, J Periodontal Res 26:440–451, 1991c.
Goodwin CS, Marshall BJ, Blincow ED, et al: Prevention of nitroimidazole resistance in
Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and
in vitro studies, J Clin Pathol 41:207–210, 1988.
Gordon JM, Walker CB, Murphy JC, et al: Tetracycline levels achievable in gingival
crevice fluid and in vitro effect on subgingival organisms. Part 1. Concentrations in
crevicular fluid after repeated doses, J Periodontol 52:609–612, 1981.
Green RJ, Harris ND: Infections and antimicrobial therapy. Pathology and Therapeutics
for Pharmacists. A Basis for Clinical Pharmacy Practice, London, 1993, Chapman and
Hall, 548-581, Ch. 12.
Greenstein G: Local drug delivery in the treatment of periodontal diseases: assessing the
clinical significance of the results, J Periodontol 77:565–578, 2006.
Haas CE, Nix DE, Schentag JJ: In vitro selection of resistant Heliobacter pylori,
Antimicrob Agents Chemother 34:1637–1641, 1990.
Haffajee AD, Uzel NG, Arguello EI, et al: Clinical and microbiological changes
associated with the use of combined antimicrobial therapies to treat ’refractory’
periodontitis, J Clin Periodontol 31:869–877, 2004.
Hall RM, Brookes DE, Stokes HW: Site-specific insertion of genes into integrins: role
of the 59-base element and determination of the recombination cross-over point, Mol
Microbiol 5:1941–1959, 1991.
Handal T, Olsen I, Walker CB, et al: Beta-lactamase production and antimicrobial
susceptibility of subgingival bacteria from refractory periodontitis, Oral Microbiol
Immunol 19:303–308, 2004.
Hansberger H: Pharmacodynamic effects of antibiotics. Studies on bacterial morphology,
initial killing, post-antibiotics effect and effective regrown time, Scand J Infect Dis
81(Suppl):1–52, 1992.
Hawley RJ, Lee LN, LeBlanc DJ: Effects of tetracycline on the streptococcal flora of
periodontal pockets, Antimicrob Agents Chemother 17:372–378, 1980.
Heijl L, Dahlen G, Sundin Y, et al: A 4-quadrant comparative study of periodontal
treatment using tetracycline-containing drug delivery fibres and scaling, J Clin
Periodontol 18:111–116, 1991.
Heimdahl A, Nord CE: Influence of doxycycline on the normal oral flora and colonisation
of the oral cavity and colon, Scand J Infect Dis 15:293–302, 1983.
Herrera D, Roldán S, Sanz M: The periodontal abscess: a review, J Clin Periodontol
27:377–386, 2000a.
Herrera D, Roldán S, González I, Sanz M: The periodontal abscess. I. Clinical and
microbiological findings, J Clin Periodontol 27:387–394, 2000b.
Herrera D, Roldán S, O’Connor A, Sanz M: The periodontal abscess. II. Microbiological
efficiency of 2 systemic antibiotic regimes, J Clin Periodontol 27:387–394, 2000c.
Herrera D, Sanz M, Jepsen S, et al: A systematic review on the effect of systemic
antimicrobials as an adjunct to scaling and root planning in periodontitis patients,
J Clin Periodontol 29(Suppl 3):136–159, 2002.
Higashi K, Morisaki K, Hayashi S, et al: Local ofloxacin delivery using a
controlled-release insert (PT-01) in the human periodontal pocket, J Periodontal Res
25:1–5, 1990.
Hiramatsu K, Hanaka H, Ino T, et al: Methicillin-resistant Staphylococcus aureus clinical
strain with reduced vancomycin susceptibility, J Antimicrob Chemother 40:135–136,
1997.
Hirschl AM, Hentschel E, Schütze K, et al: The efficiency of antimicrobial treatment of
Campylobacter pylori-associated gastritis and duodenal ulcer, Scand J Gastroenterol
23:76–81, 1988.
Hitzig C, Fosse T, Charbit Y, et al: Effects of combined topical metronidazole and
mechanical treatment on the subgingival flora of deep periodontal pockets in cuspids
and bicuspids, J Periodontol 68:613–617, 1997.
Holmes RK, Joblin MC: Genetics. In Baron S, editor: Medical Microbiology, ed 3, New
York, 1991, Churchill Livingstone, pp 91–122, Ch. 5 1991.
Hook EWD, Judson FN, Handsfield HH, et al: Auxotype/serovar diversity and
antimicrobial resistance of Neisseria gonorrhoeae in two mid-sized American cities,
Sex Transm Dis 14:141–146, 1987.
Hughes VM, Datta N: Conjunctive plasmids in bacteria of the pre-antibiotic era, Nature
302:725–726, 1983.
Huovinen P, Seppala H, Kataja J, et al: The relationship between erythromycin
consumption and antibiotic resistance in Finland. Finnish Study Group for
Antimicrobial Resistance, Ciba Found Symp 207:36–41, 1997.
Ingman T, Sorsa T, Konttinen YT, et al: Salivary collagenase, elastase- and trypsin-like
proteases as biochemical markers of periodontal tissue destruction in adult and
localized juvenile periodontitis, Oral Microbiol Immunol 8:298–305, 1993.
Jick H: Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients, Rev
Infect Dis 4:426–428, 1982.
Johnson AP, James D: Continuing increase in invasive methicillin-resistant
Staphylococcus aureus infections, Lancet 350:1710, 1997.
Joyston-Bechal S, Smales FC, Duckworth R: Effect of metronidazole on chronic
periodontal disease in subjects using a topically applied chlorhexidine gel, J Clin
Periodontol 11:53–62, 1984.
Joyston-Bechal S, Smales FC, Duckworth R: A follow-up study 3 years after
metronidazole therapy for chronic periodontal disease, J Clin Periodontol 13:944–949,
1986.
Kavi J: Mupirocin-resistant Staphylococcus aureus, Lancet 2:1472–1473, 1987.
Killoy WJ: The clinical significance of local chemotherapies, J Clin Periodontol
29(Suppl):22–29, 2002.
Kingsman AJ, Charter KF, Kingsman SM: Transposition 43rd Symposium for Society for
General Microbiology, Cambridge, 1998, Cambridge University Press.
Klinge B, Kuvatanasuhati J, Attström R, et al: The effect of topical metronidazole therapy
on experimentally-induced periodontitis in the beagle dog, J Clin Periodontol 19:702–
707, 1992a.
Klinge B, Attström R, Karring T, et al: Three regimes of topical metronidazole therapy
compared with subgingival scaling on periodontal pathology in adults, J Clin
Periodontol 19:708–714, 1992b.
Kohara Y, Adiyama K, Isona K: The physical map of the whole E. coli chromosome:
application of a new strategy for rapid analysis and sorting of a large genome, Cell
50:495–508, 1987.
Kornman KS: Controlled-release local delivery antimicrobials in periodontics: prospects
for the future, J Periodontol 64:782–791, 1993.
Kornman KS, Karl EH: The effect of long-term, low-dose tetracycline therapy on the
subgingival microflora in refractory adult periodontitis, J Periodontol 53:604–610,
1982.
Lakhssassi CN, Elhajoui N, Lodter J, et al: Antimicrobial susceptibility variation of
50 anaerobic periopathogens in aggressive periodontitis: an interindividual variability
study, Oral Microbiol Immunol 20:244–252, 2005.
Lang R, Lishner M, Ravid M: Adverse reaction to prolonged treatment with high dosage
carbenicillin and ureidopenicillins, Rev Infect Dis 13:68–72, 1991.
Larsen T: Occurrence of doxycycline-resistant bacteria in the oral cavity after local
administration of doxycycline in patients with periodontal disease, Scand J Infect Dis
23:89–95, 1991.
Larsen T, Fiehn NE: Development of resistance to metronidazole and minocycline in
vitro, J Clin Periodontol 24:254–259, 1997.
Larsen T: Susceptibility of Porphyromonas gingivalis biofilms to amoxicillin,
doxycycline and metronidazole, Oral Microbiol Immunol 17:267–271, 2002.
D.E. Laurence, D.N. Bennett, M.J. Brown, 1997, Infection and inflammation. Clinical
Pharmacology ed 8 Churchill Livingstone: New York 187–248.Section 3. Chs. 11–14.
Laurichesse H, Grimaud O, Waight P: Pneumococcal bacteria and meningitis in England
and Wales 19931995, Commun Dis Public Health 1:22–27, 1996.
Lee W, Aitken S, Kulkarni G, et al: Collagenase activity in recurrent periodontitis:
relationship to disease progression and doxycycline therapy, J Periodontal Res 26:479–
485, 1991.
Lee J-Y, Lee Y-M, Shin S-Y, et al: Effect of subantimicrobial dose doxycycline as an
effective adjunct to scaling and root planing, J Periodontol 75:1500–1508, 2004.
Levine BB: Penicillin allergy and the heterogeneous immune response to benzylpenicillin,
J Clin Investig 1996 45:1898–1906, 1996.
Lewis MA, MacFarlane TW, McGowan DA: A microbiological and clinical review of the
acute dentoalveolar abscess, Br J Oral Maxillofac Surg 28:359–366, 1990.
Lind I: Epidemiology of antibiotic-resistant Neisseria gonorrhoeae in industrialised and
developing countries, Scand J Infect Dis Suppl 169:77–82, 1990.
Lindhe J, Heijl L, Goodson JM, et al: Local tetracycline delivery using hollow fibre
devices in periodontal therapy, J Clin Periodontol 6:141–149, 1979.
Lindhe J, Liljenberg B, Adielson B, et al: Use of metronidazole as a probe in the study of
human periodontal disease, J Clin Periodontol 10:100–111, 1983.